MMP2 and prostate carcinoma: Elevated plasma MMP-2 activity has also been suggested to be prognostic for prostate cancer metastasis (Morgia et al, 2005), indicating that there may be a discrepancy between MMP2 RNA and protein levels in prostate tumours.